Genomics Market Overview
The global genomics market is
witnessing significant expansion, driven by rapid technological advancements,
increasing research initiatives, and growing applications in personalized
medicine, drug discovery, and disease diagnostics. By 2025, the market is
projected to reach a value of around USD 34.2 Billion. Looking ahead to 2035,
it is expected to expand further to about USD 66.4 Billion. This represents an
annual growth rate of 14.6% over the ten-year period.
Genomics, or gene structure and
function study, has revolutionized healthcare by enabling early detection of
diseases, targeted therapies, and precision medicine. The convergence of
artificial intelligence (AI), big data analytics, and next-generation sequencing
(NGS) technology is making genomics market size grow at a high rate. According
to genomics market analysis, increasing adoption of genome sequencing, gene
editing technology like CRISPR, and bioinformatics solutions is also propelling
market growth. The increase in incidence of genetic disorders, cancer, and rare
diseases is driving demand for genomics-based therapeutics and diagnostics,
making industry growth more substantial.
Further, advances in NGS
technology, whole genome sequencing, and microarray technology have led to a
steep decline in sequencing prices, making it more affordable to conduct
genomic testing. Government initiatives, research grant programs, and pharmaceutical
company and research institute collaborations are also fueling genomics-driven
drug development and biomarker studies. The demand for precision oncology and
personalized medicine is also fueling genomics solution adoption in clinics.
The growing focus on gene therapy, synthetic biology, and integration of
genetic information is also widening genomics application areas in
biotechnology, agriculture, and forensics. Therefore, as genomics continues to
revolutionize healthcare, prevention of diseases, and personalized therapies,
the industry will continue to grow with market trends indicating ongoing
innovations and widening adoption globally.
Genomics Market Drivers and Opportunities
Next-generation sequencing (NGS) and genome editing technologies
advancements will drive the genomics market to grow over the forecast period
Amongst some of the primary
drivers of the worldwide genomics market growth is the rapid pace of
advancement in next-generation sequencing (NGS) and genome editing technology.
The evolution of NGS has revolutionized genetic research through enhanced speed,
accuracy, and reduced cost of sequencing entire genomes. The cost reduction of
genome sequencing through advances in high-throughput sequencing platforms and
informatics software has allowed genomic research to become more accessible to
healthcare centers, pharmaceutical companies, and academic scientists.
Genome editing technologies like CRISPR-Cas9 have also driven genomics market growth with efficient and accurate gene modification capabilities. The advancements have enabled scientists to correct genetic mutations, design targeted gene therapies, and propel synthetic biology applications. Genomics market studies indicate that continued investment in gene-editing technologies, automation, and artificial intelligence-based genome sequencing platforms is transforming the landscape of genomic medicine. As demand for gene-based therapies, customized medicines, and rare disease diagnosis continues to rise, NGS and genome editing will remain at the forefront of the anticipated genomics market expansion. The adoption of cloud computing, big data analytics, and artificial intelligence (AI) in genomics research is also on the rise and simplifying data interpretation and accelerating discoveries. The collaboration between biotechnology companies, research institutes, and healthcare providers is also driving advancements in whole-genome sequencing, transcriptomics, and epigenomics and propelling genomics-based healthcare solutions adoption.
Rising incidence of genetic disorders and
cancer is a significant driver in influencing the growth of the global genomics
market
The increase
in genetic disorders, orphan diseases, and cancer is another primary driver of
the genomics market. Genetic mutations lead to a wide range of hereditary
disorders such as cystic fibrosis, sickle cell anemia, muscular dystrophy, and
Huntington’s disease, driving demand for advanced genomic testing and early
diagnosis. As genetic disorders have a high hereditary component, predictive
genetic testing, carrier testing, and prenatal testing have gained popularity,
propelling the genomics market size.
Cancer, a
leading cause of death globally, has also become a primary target of genomic
research and precision oncology. The ability to sequence tumors and identify
genetic mutations allows oncologists to design personalized treatment regimens,
targeted therapies, and immunotherapies based on a patient's genetic profile.
Genomic profiling has unveiled possibilities for liquid biopsy technologies
that make use of circulating tumor DNA (ctDNA) to detect cancer at an early
stage and monitor the evolution of disease non-invasively. Genomics market
research suggests that continuous advancements in cancer genomics,
pharmacogenomics, and biomarker discovery fuel research into new therapies and
improve patient survival rates.
Government
agencies and research institutes worldwide are investing significantly in
genomics medicine and precision healthcare, hence driving market growth. For
instance, in January 2023, SOPHiA GENETIC collaborated with Memorial Sloan
Kettering Cancer Center (MSK), a U.S. Cancer Center, to offer scientists and
clinicians solutions to enhance analytical and testing capacity. As more
individuals become knowledgeable about genomics applications in preventing
illness, early detection, and precision medicine, healthcare is witnessing a
rapid adoption of genomics technology, driving forecasted expansion trends in
the genomics market.
Integrating AI and Big Data in Genomic Research
The intersection of artificial intelligence (AI) and big data analytics is enabling new frontiers in
genomics research, pharmaceutical discovery, and medical diagnosis. Artificial
intelligence-powered algorithms can analyze vast amounts of genomic data to
recognize patterns of illness and predict treatment outcomes with precision.
Bioinformatics software, machine learning algorithms, and deep-learning
platforms are facilitating genomic sequencing, gene-expression studies, and
biomarker discovery. Based on genomics market forecast trends, applications of predictive
genomics through artificial intelligence, cloud-based platforms of
bioinformatics, and automated genome interpretation are transforming healthcare
and biotechnology industries. Future development of genomics AI platforms will
enhance research capabilities immensely, accelerate innovations, and create new
opportunities in prevention of diseases, regenerative medicine, and uses of
synthetic biology
Genomics Market Scope
Report
Attributes |
Description |
Market Size in 2025 |
USD 34.2 Billion |
Market
Forecast in 2035 |
USD 66.4
Billion |
CAGR % 2025-2035 |
14.6% |
Base
Year |
2024 |
Historic Data |
2020-2024 |
Forecast
Period |
2025-2035 |
Report USP
|
Production, Consumption, company
share, company heatmap, company production capacity, growth factors and more |
Segments
Covered |
|
Regional Scope |
|
Country
Scope |
|
Genomics Market Report Segmentation Analysis
The global genomics market industry
analysis is segmented into by Type, by Technology, by Application, by End-user and
by Region.
The Type segment will have the highest market share in the global genomics
market during the forecast period.
By Type, market is segmented into products and services, with products being the dominant segment with 52.0% market share. Products segment includes instruments & software and consumables, both of which have a key function in genomic research, clinical diagnostics, and drug discovery. Demand for next-generation sequencing (NGS) platforms, PCR systems, microarrays, and bioinformatics software is driving high growth in this segment. Adoption of genomics-based healthcare solutions, precision medicine, and genomic data analysis through artificial intelligence is also driving market expansion. Genomics market analysis states that products have the largest market share due to continuous advances in sequencing technology, automation, and data analytics software that is making genomic studies more efficient and precise.
The Polymerase Chain Reaction (PCR) dominated the market in 2024 and is
projected to grow at the highest CAGR over the forecast period.
Based on technology type,
genomics market is segmented into Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger
Sequencing, and Others. In 2025, Polymerase Chain Reaction (PCR) will dominate
the market. PCR is a prevalent technology applied in genomic research, clinical
diagnosis, forensic uses, and infectious diseases testing that accounts for its
significant market share in genomics market size. The demand for PCR-based gene
testing, molecular testing, and targeted gene amplification techniques is a key
adoption driver. Genomics market study suggests that low cost, high accuracy,
and rapid processing of PCR have been driving factors to make it a market
leader.
The diagnostics segment is
predicted to grow at the highest CAGR over the forecast period.
Application market is divided into Drug Discovery and Development, Diagnostics, Precision Medicine, Agriculture and Animal Research, and Other Applications. In 2025, Diagnostics being the largest application segment market. The increasing demand for genomics-based diagnostic products to diagnose diseases, genetic conditions, and early-stage cancers has been driving this application market in genomics market size. With the growing prevalence of genetic disorders, rare diseases, and infectious diseases, genomics-driven diagnostics have become essential for early disease detection, risk assessment, and personalized treatment planning.
The Pharmaceutical & Biotechnological Companies segment is expected
to dominate the market during the forecast period.
End user genomics market is
segmented into Research Institutes, Healthcare Facilities & Diagnostic
Centers, Pharmaceutical & Biotechnological Companies, and Contract Research
Organizations (CROs), with Pharmaceutical & Biotechnological Companies
accounting for the largest share. Pharmaceutical & Biotechnological
Companies drive genomics-based drug development, precision medicine, gene
therapy research, and biomarker studies that drive genomics market size growth.
The following segments are part of an in-depth analysis of the global genomics
market:
Market
Segments |
|
By Type |
|
By Technology |
|
By Application |
|
By End-user |
|
Genomics Market Share Analysis by Region
North America is
projected to hold the largest share of the global genomics market over the
forecast period.
By 2025, North America has the
largest market share of 44.1% in genomics market size with top biotechnology
and pharmaceutical players present in the region, well-developed healthcare
infrastructure, and high government expenditure in genomic research. The demand
for next-generation sequencing (NGS), polymerase chain reaction (PCR), and
genome editing technologies is driving genomics market growth in North America.
The rising adoption of precision medicine, targeted therapies, and
genomics-based tests is also supporting the region's market supremacy.
According to genomics market studies, rising cases of cancer, genetic
disorders, and orphan diseases have led to more genomic testing, biomarker
discovery, and applications of pharmacogenomics in the region. Government
initiatives such as the All of Us Research Program and 100,000 Genomes Project
are supporting advancements in genomic medicine, AI-based genetic analytics,
and cloud-based genomic information storage solutions. In addition, leading
research institutions and biopharmaceutical companies investing in gene therapy,
synthetic biology, and CRISPR gene-editing technology in North America propel
the forecasted growth of the genomics market. The adoption of automation,
bioinformatics software, and AI-based genomic platforms will continue to drive
innovations to help North America remain at the forefront of global genomics
market trends.
However, Asia-Pacific (APAC) is
poised to have the highest CAGR in genomics market forecast trends. The region
is experiencing accelerated development with more biotechnology research,
government investment in genomic medicine, and healthcare infrastructure
improvements. The demand for genomic sequencing, precision diagnosis, and
artificial intelligence-based bioinformatics solutions is rising in countries
like China, India, and Japan. As more focus is being placed on genetic
research, disease prevention, and genome-based pharmaceutical development, APAC
is poised to be a driving factor in shaping the genomics market of tomorrow.
Genomics Market Competition Landscape Analysis
the global genomics market is
poised for significant growth, with key players investing heavily in technology
and infrastructure. These companies are actively engaged in research and
development, strategic partnerships, and large-scale project implementations to
enhance their market positions.
Global Genomics
Market Recent Developments News:
In May 2024, Sophia Genetics announced
that it will be collaborating with Microsoft and NVIDIA to harness their
technology and genomics capabilities to offer a streamlined and scalable
solution to healthcare institutions to perform whole genome sequencing (WGS)
analyses with a vision to make it accessible to customers within a year.
In May 2024, Bruker Corporation announced that it had finalized its acquisition of NanoString Technologies, Inc.'s business. The acquisition strengthened its portfolio as the company has now finalized acquiring substantially all of the assets and rights to NanoString's business, including nCounter, GeoMx, CosMx and AtoMx product offerings, at approximately USD 392.6 million in cash and with the assumption of some liabilities.
The global genomics market is
dominated by a few large companies, such as
·
Abbott
·
Agilent Technologies, Inc.
·
BD
·
BGI Group
·
Bio-Rad Laboratories, Inc.
·
Charles River Laboratories
·
Danaher Corporation
·
Eppendorf SE
·
Eurofins Scientific
·
F. Hoffmann-La Roche Ltd.
·
Illumina, Inc.
·
IQVIA Inc.
·
Merck KGaA
·
Oxford Nanopore Technologies plc.
·
Thermo Fisher Scientific Inc.
·
Others
1.
Global
Genomics Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Genomics Market Scope and
Market Estimation
1.2.1. Global Genomics Overall Market
Size (US$ Bn), Market CAGR (%), Market forecast (2025 - 2035)
1.2.2. Global Genomics Market Revenue
Share (%) and Growth Rate (Y-o-Y) from 2021 - 2035
1.3. Market Segmentation
1.3.1. Type of Global Genomics Market
1.3.2. Technology of Global Genomics
Market
1.3.3. Application of Global Genomics
Market
1.3.4. End User of Global Genomics
Market
1.3.5. Region of Global Genomics Market
2.
Executive Summary
2.1. Demand Side Trends
2.2. Key Market Trends
2.3. Market Demand (US$ Bn) Analysis
2021 – 2024 and Forecast, 2025 – 2035
2.4. Demand and Opportunity
Assessment
2.5. Demand Supply Scenario
2.6. Market Dynamics
2.6.1. Drivers
2.6.2. Limitations
2.6.3. Opportunities
2.6.4. Impact Analysis of Drivers and
Restraints
2.7. Pricing Trends Analysis
2.8. Overview of Technology Developments
2.9. Porter’s Five Forces Analysis
2.9.1. Bargaining Power of Suppliers
2.9.2. Bargaining Power of Buyers
2.9.3. Threat of Substitutes
2.9.4. Threat of New Entrants
2.9.5. Competitive Rivalry
2.10. PEST Analysis
2.10.1. Political Factors
2.10.2. Economic Factors
2.10.3. Social Factors
2.10.4. Technology Factors
2.11. Value Chain / Ecosystem Analysis
2.12. Key Regulation
3.
Global Genomics Market Estimates & Historical Trend Analysis (2021 - 2024)
4.
Global Genomics Market Estimates & Forecast Trend Analysis, by
Type
4.1. Global Genomics Market Revenue
(US$ Bn) Estimates and Forecasts, by Type, 2021 - 2035
4.1.1. Products
4.1.1.1.
Instruments
& Software
4.1.1.2.
Consumables
4.1.2. Services
5.
Global Genomics Market Estimates & Forecast Trend Analysis, by
Technology
5.1. Global Genomics Market Revenue
(US$ Bn) Estimates and Forecasts, by Technology, 2021 - 2035
5.1.1. Polymerase Chain Reaction (PCR)
5.1.2. Next-generation Sequencing (NGS)
5.1.3. Microarray
5.1.4. Sanger Sequencing
5.1.5. Others
6.
Global Genomics Market Estimates & Forecast Trend Analysis, by
Application
6.1. Global Genomics Market Revenue
(US$ Bn) Estimates and Forecasts, by Application, 2021 - 2035
6.1.1. Drug Discovery and Development
6.1.2. Diagnostics
6.1.3. Precision Medicine
6.1.4. Agriculture and Animal Research
6.1.5. Other Applications
7.
Global Genomics Market Estimates & Forecast Trend Analysis, by
End User
7.1. Global Genomics Market Revenue
(US$ Bn) Estimates and Forecasts, by End User, 2021 - 2035
7.1.1.Research
Institutes
7.1.2.Healthcare
Facilities & Diagnostic Centers
7.1.3.Pharmaceutical
& Biotechnological Companies
7.1.4.Contract
Research Organization (CROs)
8.
Global Genomics Market Estimates & Forecast Trend Analysis,
by Region
8.1. Global Genomics Market Revenue
(US$ Bn) Estimates and Forecasts, by Region, 2021 - 2035
8.1.1. North America
8.1.2. Eastern Europe
8.1.3. Western Europe
8.1.4. Asia Pacific
8.1.5. Middle East & Africa
8.1.6. Latin America
9.
North
America Genomics Market: Estimates & Forecast Trend Analysis
9.1.
North
America Genomics Market Assessments & Key Findings
9.1.1. North America Genomics Market
Introduction
9.1.2. North America Genomics Market
Size Estimates and Forecast (US$ Billion) (2021 - 2035)
9.1.2.1. By Type
9.1.2.2. By Technology
9.1.2.3. By Application
9.1.2.4. By End User
9.1.2.5. By Country
9.1.2.5.1. The U.S.
9.1.2.5.2. Canada
9.1.2.5.3. Mexico
10. Western Europe Genomics
Market: Estimates & Forecast Trend
Analysis
10.1. Western Europe Genomics Market
Assessments & Key Findings
10.1.1. Western Europe Genomics Market
Introduction
10.1.2. Western Europe Genomics Market
Size Estimates and Forecast (US$ Billion) (2021 - 2035)
10.1.2.1. By Type
10.1.2.2. By Technology
10.1.2.3. By Application
10.1.2.4. By End User
10.1.2.5. By Country
10.1.2.5.1.
Germany
10.1.2.5.2.
Italy
10.1.2.5.3.
U.K.
10.1.2.5.4.
France
10.1.2.5.5.
Spain
10.1.2.5.6.
Benelux
10.1.2.5.7.
Nordics
10.1.2.5.8. Rest
of W. Europe
11. Eastern Europe Genomics
Market: Estimates & Forecast Trend
Analysis
11.1. Eastern Europe Genomics Market
Assessments & Key Findings
11.1.1. Eastern Europe Genomics Market
Introduction
11.1.2. Eastern Europe Genomics Market
Size Estimates and Forecast (US$ Billion) (2021 - 2035)
11.1.2.1. By Type
11.1.2.2. By Technology
11.1.2.3. By Application
11.1.2.4. By End User
11.1.2.5. By Country
11.1.2.5.1.
Russia
11.1.2.5.2.
Hungary
11.1.2.5.3.
Poland
11.1.2.5.4.
Balkan & Baltics
11.1.2.5.5. Rest of E. Europe
12. Asia Pacific Genomics
Market: Estimates & Forecast Trend
Analysis
12.1. Asia Pacific Market Assessments
& Key Findings
12.1.1. Asia Pacific Genomics Market
Introduction
12.1.2. Asia Pacific Genomics Market
Size Estimates and Forecast (US$ Billion) (2021 - 2035)
12.1.2.1. By Type
12.1.2.2. By Technology
12.1.2.3. By Application
12.1.2.4. By End User
12.1.2.5. By Country
12.1.2.5.1. China
12.1.2.5.2. Japan
12.1.2.5.3. India
12.1.2.5.4. Australia & New Zealand
12.1.2.5.5. South Korea
12.1.2.5.6. ASEAN
12.1.2.5.7. Rest of Asia Pacific
13. Middle East & Africa Genomics
Market: Estimates & Forecast Trend
Analysis
13.1. Middle East & Africa Market
Assessments & Key Findings
13.1.1. Middle
East & Africa Genomics
Market Introduction
13.1.2. Middle
East & Africa Genomics
Market Size Estimates and Forecast (US$ Billion) (2021 - 2035)
13.1.2.1. By Type
13.1.2.2. By Technology
13.1.2.3. By Application
13.1.2.4. By End User
13.1.2.5. By Country
13.1.2.5.1. UAE
13.1.2.5.2. Saudi
Arabia
13.1.2.5.3. Turkey
13.1.2.5.4. South
Africa
13.1.2.5.5. Rest of
MEA
14. Latin America
Genomics Market: Estimates &
Forecast Trend Analysis
14.1. Latin America Market Assessments
& Key Findings
14.1.1. Latin America Genomics Market
Introduction
14.1.2. Latin America Genomics Market
Size Estimates and Forecast (US$ Billion) (2021 - 2035)
14.1.2.1. By Type
14.1.2.2. By Technology
14.1.2.3. By Application
14.1.2.4. By End User
14.1.2.5. By Country
14.1.2.5.1. Brazil
14.1.2.5.2. Argentina
14.1.2.5.3. Colombia
14.1.2.5.4. Rest of
LATAM
15. Country Wise Market:
Introduction
16. Competition Landscape
16.1. Global Genomics Market Product
Mapping
16.2. Global Genomics Market
Concentration Analysis, by Leading Players / Innovators / Emerging Players /
New Entrants
16.3. Global Genomics Market Tier
Structure Analysis
16.4. Global Genomics Market
Concentration & Company Market Shares (%) Analysis, 2023
17. Company Profiles
17.1. Abbott
17.1.1. Company Overview & Key Stats
17.1.2. Financial Performance & KPIs
17.1.3. Product Portfolio
17.1.4. SWOT Analysis
17.1.5. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
17.2. Abbott
17.3. Agilent
Technologies, Inc.
17.4. BD
17.5. BGI Group
17.6. Bio-Rad
Laboratories, Inc.
17.7. Charles River Laboratories
17.8. Danaher Corporation
17.9. Eppendorf SE
17.10. Eurofins Scientific
17.11. F. Hoffmann-La
Roche Ltd.
17.12. Illumina, Inc.
17.13. IQVIA Inc.
17.14. Merck KGaA
17.15. Oxford Nanopore
Technologies plc.
17.16. Thermo Fisher
Scientific Inc.
17.17. Others
18. Research
Methodology
18.1. External Transportations /
Databases
18.2. Internal Proprietary Database
18.3. Primary Research
18.4. Secondary Research
18.5. Assumptions
18.6. Limitations
18.7. Report FAQs
19. Research
Findings & Conclusion
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Genomics market was valued at USD 34.2 Billion in 2025.
Genomics market size will increase at approximate CAGR of 14.6% during the forecasted period.
Major companies operating within the market are Abbott, Agilent Technologies, Inc., BD, BGI Group, Bio-Rad Laboratories, Inc., Charles River Laboratories, Danaher Corporation, Eppendorf SE, Eurofins Scientific, F. Hoffmann-La Roche Ltd. and others.
Europe dominates the market with an active share of 44.1%.
Only Three Thousand Four Hundred Ninety Nine US dollar
Only Four Thousand Four Hundred Ninety Nine US dollar
Only Five Thousand Four Hundred Ninety Nine US dollar